Buscar
Collplant Biotechnologies Ltd
CLGNAñadir a la lista de seguimiento
0.340USD
-0.009-2.63%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
4.36MCap. mercado
PérdidaP/E TTM
Más Datos de Collplant Biotechnologies Ltd Compañía
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Información de Collplant Biotechnologies Ltd
Símbolo de cotizaciónCLGN
Nombre de la empresaCollplant Biotechnologies Ltd
Fecha de salida a bolsaSep 01, 1993
Director ejecutivoRotem (Eran)
Número de empleados57
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 01
Dirección4 Oppenheimer Street
CiudadREHOVOT
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal7670104
Teléfono972732325600
Sitio Webhttps://www.collplant.com
Símbolo de cotizaciónCLGN
Fecha de salida a bolsaSep 01, 1993
Director ejecutivoRotem (Eran)
Ejecutivos de Collplant Biotechnologies Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Collplant Biotechnologies Ltd?
Los cinco principales accionistas de Collplant Biotechnologies Ltd son: Mr. Yehiel Tal
¿Cuántas instituciones poseen acciones de Collplant Biotechnologies Ltd (CLGN)?
A fecha de 2026Q1, 35 instituciones poseen acciones de Collplant Biotechnologies Ltd, con un valor de mercado combinado de aproximadamente 1.89M, lo que representa el 13.14% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -218892.00.
¿Cuál es la mayor fuente de ganancias de Collplant Biotechnologies Ltd?
El 2026Q1, el segmento empresarial Revenues from licensing agreement generó la ganancia más alta para Collplant Biotechnologies Ltd, ascendiendo a 2.00M y representando el 84.35% de la ganancia total.